CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Total share-based compensation expense	$ 21,393	$ 25,371
Research and development
Total share-based compensation expense	5,104	8,048
Selling, general and administrative
Total share-based compensation expense	$ 16,289	16,966
Restructuring and related expenses
Total share-based compensation expense		$ 357